Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 48,487 | -38,405 | 68,217 | 54,617 | 47,407 |
| Cost of Goods | 2,138 | -1,070 | 1,592 | 1,651 | 1,645 |
| Gross Profit | 46,349 | -37,335 | 66,625 | 52,966 | 45,762 |
| Operating Expenses | 112,617 | 47,445 | 98,928 | 88,932 | 93,956 |
| Operating Income | -66,130 | -84,850 | -31,711 | -35,315 | -47,549 |
| Interest Expense | 2,515 | 4,610 | 4,899 | 4,852 | 5,321 |
| Other Income | -7,274 | 690 | 1,014 | 1,204 | -684 |
| Pre-tax Income | -75,919 | -88,770 | -35,596 | -38,963 | -53,554 |
| Income Tax | 52 | 4 | 43 | 49 | 313 |
| Net Income Continuous | -75,971 | -88,774 | -35,639 | -39,012 | -53,867 |
| Net Income | $-75,971 | $-51,573 | $-35,639 | $-39,012 | $-53,867 |
| EPS Basic Total Ops | -1.20 | -0.82 | -0.59 | -0.64 | -0.96 |
| EPS Basic Continuous Ops | -1.20 | -1.44 | -0.59 | -0.64 | -0.96 |
| EPS Diluted Total Ops | -1.20 | -0.82 | -0.59 | -0.64 | -0.96 |
| EPS Diluted Continuous Ops | -1.20 | -1.44 | -0.59 | -0.64 | -0.96 |
| EBITDA(a) | $-59,038 | $-87,777 | $-21,004 | $-26,087 | $-38,561 |